v3.25.0.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Common Stock [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Previously Reported [Member]
AOCI Including Portion Attributable to Noncontrolling Interest [Member]
AOCI Including Portion Attributable to Noncontrolling Interest [Member]
Previously Reported [Member]
Total
Previously Reported [Member]
Balances at Dec. 31, 2021 $ 12   $ 763,087   $ (663,681)     $ 99,418  
Balance, shares at Dec. 31, 2021 12,430,788                  
Cumulative effect adjustment ASU 2016-02       3,993     3,993  
Reclassification of previously exercised stock options   441       441  
Reclassification of previously exercised stock options, shares 13,125                  
Exercise of stock options   948       948  
Exercise of stock options, shares 171,047                  
Purchase and retirement of common shares   (86)       (86)  
Purchase and retirement of common shares, shares (1,050)                  
Exercise of warrants $ 2   46,489       46,491  
Exercise of warrants, shares 1,328,189                  
Common stock issued pursuant to short-term debt conversion $ 1   4,098     (11)   4,088  
Common stock issued pursuant to short-term debt conversion, shares 262,797                  
Vesting of restricted stock units         0  
Vesting of restricted stock units, in shares 23,252                  
Tax withholding on vesting of restricted stock units   (132)       (132)  
Tax withholding on vesting of restricted stock units, shares (7,067)                  
Stock-based compensation expense   15,856       15,856  
Issuance of common stock and warrants in PIPE Offering, net of offering expenses   7,651       7,651  
Issuance of common stock and warrants in PIPE Offering, net of offering expenses, in shares 405,406                  
Issuance of common stock in ATM offering, net of commissions and offering expenses   6,021       6,021  
Issuance of common stock in ATM offering, net of commissions and offering expenses, shares 265,641                  
Change in fair value of debt due to change in credit risk, net of tax       20   20  
Net income (loss)     14,192     14,192  
Balances at Dec. 31, 2022 $ 15 $ 1 844,373 $ 844,387 (645,496) $ (645,496) 9 $ 9 198,901 $ 198,901
Balance, shares at Dec. 31, 2022 14,892,129                  
Exercise of stock options     300       300
Exercise of stock options, shares 107,100                  
Common stock issued pursuant to short-term debt conversion     3,510     (152)   3,358
Common stock issued pursuant to short-term debt conversion, shares 365,612                  
Tax withholding on vesting of restricted stock units     (53)       (53)
Tax withholding on vesting of restricted stock units, shares (8,110)                  
Stock-based compensation expense     3,988       3,988
Change in fair value of debt due to change in credit risk, net of tax         2,810   2,810
Net income (loss)       (64,017)     (64,017)
Issuance of common stock for stem-cells to be used in research and development     1,000       1,000
Issuance of common stock for stem-cells to be used in research and development, shares 169,492                  
Issuance of warrants on senior secured bridge loan     274       274
Vesting of restricted stock units          
Vesting of restricted stock units, shares 25,339                  
Issuance of common stock in PIPE Offering, net of offering expenses     8,931       8,931
Issuance of common stock in PIPE Offering, net of offering expenses, shares 938,183                  
Issuance of common stock under ATM Agreement     136       136
Issuance of common stock under ATM Agreement, shares 13,296                  
Balances at Mar. 31, 2023 $ 1   862,473   (709,513)   2,667   155,628  
Balance, shares at Mar. 31, 2023 16,503,041                  
Balances at Dec. 31, 2022 $ 15 1 844,373 844,387 (645,496) (645,496) 9 9 198,901 198,901
Balance, shares at Dec. 31, 2022 14,892,129                  
Net income (loss)                 (205,842)  
Balances at Sep. 30, 2023 $ 2   879,188   (851,338)   2,395   30,247  
Balance, shares at Sep. 30, 2023 19,365,913                  
Balances at Dec. 31, 2022 $ 15 1 844,373 844,387 (645,496) (645,496) 9 9 198,901 198,901
Balance, shares at Dec. 31, 2022 14,892,129                  
Exercise of stock options   304       304  
Exercise of stock options, shares 108,637                  
Common stock issued pursuant to short-term debt conversion $ 1   4,598     (155)   4,444  
Common stock issued pursuant to short-term debt conversion, shares 559,481                  
Tax withholding on vesting of restricted stock units   (101)       (101)  
Tax withholding on vesting of restricted stock units, shares (19,130)                  
Stock-based compensation expense   15,017       15,017  
Change in fair value of debt due to change in credit risk, net of tax       146   146  
Net income (loss)     (196,295)     (196,295)  
Issuance of common stock in Registered Direct Offering, net of offering expenses $ 2   1,320       1,322  
Issuance of common stock in Registered Direct Offering, net of offering expenses, shares 1,780,220                  
Common stock issued pursuant to short-term debt maturity extension   712       712  
Common stock issued pursuant to short-term debt maturity extension, shares 270,731                  
Fair value of warrant modification for professional services   403       403  
Issuance of common stock for stem-cells to be used in research and development   1,000       1,000  
Issuance of common stock for stem-cells to be used in research and development, shares 169,492                  
Issuance of warrants on senior secured bridge loan   2,016       2,016  
Vesting of restricted stock units         0  
Vesting of restricted stock units, shares 83,759                  
Issuance of common stock in PIPE Offering, net of offering expenses $ 1   12,680       12,681  
Issuance of common stock in PIPE Offering, net of offering expenses, shares 1,519,579                  
Issuance of common stock under ATM Agreement   136       136  
Issuance of common stock under ATM Agreement, shares 13,296                  
Issuance of warrants (C.V. Starr & RWI)   274       274  
Balances at Dec. 31, 2023 $ 19 2 882,732 882,749 (841,791) (841,791) 40,960 40,960
Balance, shares at Dec. 31, 2023 19,378,192                  
Balances at Mar. 31, 2023 $ 1   862,473   (709,513)   2,667   155,628  
Balance, shares at Mar. 31, 2023 16,503,041                  
Exercise of stock options   4       4  
Exercise of stock options, shares 1,537                  
Common stock issued pursuant to short-term debt conversion   282     (10)   272  
Common stock issued pursuant to short-term debt conversion, shares 38,085                  
Tax withholding on vesting of restricted stock units   (33)       (33)  
Tax withholding on vesting of restricted stock units, shares (4,589)                  
Stock-based compensation expense   3,856       3,856  
Change in fair value of debt due to change in credit risk, net of tax       (269)   (269)  
Net income (loss)     (47,949)     (47,949)  
Issuance of common stock in Registered Direct Offering, net of offering expenses $ 1   1,225       1,226  
Issuance of common stock in Registered Direct Offering, net of offering expenses, shares 923,077                  
Vesting of restricted stock units          
Vesting of restricted stock units, shares 39,178                  
Issuance of common stock in PIPE Offering, net of offering expenses   3,750       3,750  
Issuance of common stock in PIPE Offering, net of offering expenses, shares 581,395                  
Issuance of warrants (C.V. Starr & RWI)   2,016       2,016  
Balances at Jun. 30, 2023 $ 2   873,573   (757,462)   2,388   118,501  
Balance, shares at Jun. 30, 2023 18,081,724                  
Common stock issued pursuant to short-term debt conversion   807     7   814  
Common stock issued pursuant to short-term debt conversion, shares 155,785                  
Tax withholding on vesting of restricted stock units   (1)       (1)  
Tax withholding on vesting of restricted stock units, shares (275)                  
Stock-based compensation expense   3,598       3,598  
Net income (loss)     (93,876)     (93,876)  
Issuance of common stock in Registered Direct Offering, net of offering expenses   96       96  
Issuance of common stock in Registered Direct Offering, net of offering expenses, shares 857,143                  
Common stock issued pursuant to short-term debt maturity extension   712       712  
Common stock issued pursuant to short-term debt maturity extension, shares 270,731                  
Fair value of warrant modification for professional services   403       403  
Vesting of restricted stock units          
Vesting of restricted stock units, shares 805                  
Balances at Sep. 30, 2023 $ 2   879,188   (851,338)   2,395   30,247  
Balance, shares at Sep. 30, 2023 19,365,913                  
Balances at Dec. 31, 2023 $ 19 2 882,732 882,749 (841,791) (841,791) 40,960 40,960
Balance, shares at Dec. 31, 2023 19,378,192                  
Vesting of restricted stock units            
Vesting of restricted stock units, in shares 233,361                  
Tax withholding on vesting of restricted stock units     (357)       (357)
Tax withholding on vesting of restricted stock units, shares (80,672)                  
Stock-based compensation expense     2,966       2,966
Issuance of common stock and warrants in PIPE Offering, net of offering expenses     6,000         6,000
Issuance of common stock and warrants in PIPE Offering, net of offering expenses, in shares 2,141,098                  
Net income (loss)       (22,013)     (22,013)
Issuance of common stock to Yorkville for debt extension and SEPA commitment fee     317       317
Issuance of common stock to Yorkville for debt extension and SEPA commitment fee, in shares 116,964                  
Issuance and modification of warrants to RWI and C.V. Starr     3,322       3,322
Issuance of warrants to Palantir as consideration for settlement agreement     50       50
Issuance of warrants to Palantir as consideration for settlement agreement, in shares 20,000                  
Retirement of shares in connection with reverse stock split          
Retirement of shares in connection with reverse stock split, in shares (191)                  
Balances at Mar. 31, 2024 $ 2   895,047   (863,804)     31,245  
Balance, shares at Mar. 31, 2024 21,808,752                  
Balances at Dec. 31, 2023 $ 19 $ 2 882,732 $ 882,749 (841,791) $ (841,791) 40,960 $ 40,960
Balance, shares at Dec. 31, 2023 19,378,192                  
Net income (loss)                 (44,599)  
Balances at Sep. 30, 2024 $ 2   903,670   (886,390)   (2)   17,280  
Balance, shares at Sep. 30, 2024 21,984,614                  
Balances at Mar. 31, 2024 $ 2   895,047   (863,804)     31,245  
Balance, shares at Mar. 31, 2024 21,808,752                  
Vesting of restricted stock units          
Vesting of restricted stock units, in shares 87,180                  
Tax withholding on vesting of restricted stock units          
Tax withholding on vesting of restricted stock units, shares (2,655)                  
Stock-based compensation expense   2,990       2,990  
Net income (loss)     (6,488)     (6,488)  
Issuance and modification of warrants to RWI and C.V. Starr   (61)       (61)  
Issuance of warrants to Palantir as consideration for settlement agreement   125       125  
Issuance of warrants to Palantir as consideration for settlement agreement, in shares 40,584                  
Balances at Jun. 30, 2024 $ 2   898,101   (870,292)     27,811  
Balance, shares at Jun. 30, 2024 21,933,861                  
Vesting of restricted stock units          
Vesting of restricted stock units, in shares 75,472                  
Tax withholding on vesting of restricted stock units   (73)       (73)  
Tax withholding on vesting of restricted stock units, shares (24,719)                  
Stock-based compensation expense   2,672       2,672  
Change in fair value of debt due to change in credit risk, net of tax       (2)   (2)  
Net income (loss)     (16,098)     (16,098)  
Reclassification of warrants from liability classified to equity classified   2,970       2,970  
Balances at Sep. 30, 2024 $ 2   $ 903,670   $ (886,390)   $ (2)   $ 17,280  
Balance, shares at Sep. 30, 2024 21,984,614